Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vra8g2539 | ATGGCAGCAAGATTCTCTCGCCTTGCTCCTTTTCTGGTTTTTCATTTTCTTCTTCTCACGGTTCAAGGTTCCAGTAACCCAGATTTCGACGCTCTCGTGGCCTTCAAAACCGCTTCAGACACTTCCCAGAAGCTCACAACATGGAACACCAGCAGCACCAGCCCCTGTTCCTGGAGCGGCGTGTCGTGCATTGGCGACCGTGTCTCCCGACTCGTTCTCGAAAACCTTGACCTCCAAGGCTCCATTCATCCCTTGACTTCTCTAACTCAGCTCCGAGTTCTCAGTCTCAAAGGAAACCATTTCTCCGGTCCCGTTCCCGACCTCTCCAACCTCACCGCCCTCAAACTCCTCTTCTTGTCTCGCAACGCCTTCTCCGGCGAGTTTCCGGGGACCGTCACGTCGCTCTTTCGCCTCTACCGACTCGATCTGTCCAACAACAACTTCTCCGGCGAGATTTCGGCGACGGTCTCCCACTTGACCCACCTCCTCACTCTCCGCCTCGACGGGAACAAGTTCTCCGGCCACATTCCTGACTTCAACCTCCCCGACCTCCAAGAATTCAACGTCTCCGGCAACCGCCTCTCCGGCGAGATACCCAAAGCATTATCAAGTTTCCCCGAATCATCGTTCGGGCAAAACCCGTTTCTCTGTGGTGCTCCAGTTAAAAAATGCGCATCCGACCCAACCAAACCCGGATCAGAAGGCGCCATTGCTTCGCCGTTGTTACCACAGAACCATAACAACCCAACACCTACGGTATCATCTTCACCAAGCTCAATGCCAAAAACGTCAACCCCAATGTCAAGCAGTAAAAGCCACGAGAAGGGTGCTTCTAAAATAAGCCCGGTGGCGCTTATAGCTATTATAGTTGGTGATGTTTTGGTTCTTGCAATAGTGTCTTTGCTTTTGTATTGTTACTTCTGGAGAAACTACAAGTTAAAAGAAGGGAAGGGAACGAAGCTTTTTGAGAGTGAGAAGATTGTGTATTCGTCAAGTCCGTACCCTGCTCAGGGAGGGTTTGAGAGGGGTCGCATGGTGTTCTTCGAGGGTGAGAAAAGGTTTGAACTTGAGGACTTGCTGCGAGCATCTGCGGAAATGCTTGGAAAGGGAGGATTTGGGACCGCGTATAAGGCAGTGCTCGATGATGGGAACGTGGTTGCGGTGAAGAGACTGAAGGACGCGCAGATTACAGGGAAGAGGGAATTCGAGCAACACATGGAGGTGTTGGGAAGGTTAAGGCATCCAAATGTCGTTAGTTTGAGAGCTTACTATTTTGCGCGCGAGGAGAAGTTGCTGGTCTATGATTACATGCCCAATGCCACCTTGTTCTGGCTCCTTCACGGGAACCGAGGACCCGGACGAACCCCACTGGACTGGACCACGAGGCTGAAAATAGCAGCGGGAGCGGCGAGAGGTGTGGCTTTCATTCATAACTCGTGCAAGTCCATTAGACTCACCCACGGTAACATCAAATCCACCAACATCTTACTCGACAAGCAGGGCAACGCGCACGTGTCTGATTTTGGGCTCTCGGTTTTCGCGGGGCCAGGCCCATTGGGTGGGAGGCCCAACGGCTATCGCGCGCCGGAAGCATCGGATGGTCGAAAACAGACCCAGAAGTCTGACGTGTACTCTTTCGGTGTGCTCCTGCTGGAGATTCTAACCGGGAAGTGCCCCTCTGTGGTGGAGAGTGCAGGCAGTGCTTACGGTGGGGTGGTGGACCTGCCGAGGTGGGTCCAGTCGGTGGTGAGGGAAGAATGGACCGCTGAAGTGTTTGATTTGGAACTGATGAGGTATAAGGATATTGAGGAGGAGATGGTGGGGTTGCTTCAGATTGCGATGACGTGTACCGCGGCTGCACCTGATCAACGGCCCAGGATGAGCCACGTGGTGAAGATGATTGAGGAGTTGCGTGGGGTCGAGGTGTCGCCGTGTCATGACTCGACGGACTCTGTTTCCGAGTCACCCTCCATGTCTGAAGATGCGTGTGGAACGAGTCAGTGA | 2004 | 0.5329 | MAARFSRLAPFLVFHFLLLTVQGSSNPDFDALVAFKTASDTSQKLTTWNTSSTSPCSWSGVSCIGDRVSRLVLENLDLQGSIHPLTSLTQLRVLSLKGNHFSGPVPDLSNLTALKLLFLSRNAFSGEFPGTVTSLFRLYRLDLSNNNFSGEISATVSHLTHLLTLRLDGNKFSGHIPDFNLPDLQEFNVSGNRLSGEIPKALSSFPESSFGQNPFLCGAPVKKCASDPTKPGSEGAIASPLLPQNHNNPTPTVSSSPSSMPKTSTPMSSSKSHEKGASKISPVALIAIIVGDVLVLAIVSLLLYCYFWRNYKLKEGKGTKLFESEKIVYSSSPYPAQGGFERGRMVFFEGEKRFELEDLLRASAEMLGKGGFGTAYKAVLDDGNVVAVKRLKDAQITGKREFEQHMEVLGRLRHPNVVSLRAYYFAREEKLLVYDYMPNATLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGVAFIHNSCKSIRLTHGNIKSTNILLDKQGNAHVSDFGLSVFAGPGPLGGRPNGYRAPEASDGRKQTQKSDVYSFGVLLLEILTGKCPSVVESAGSAYGGVVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMTCTAAAPDQRPRMSHVVKMIEELRGVEVSPCHDSTDSVSESPSMSEDACGTSQ* | 668 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vra8g2539 | 667 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE PXC1 | 14 | 653 | - | - | |
Vra8g2539 | 667 | Gene3D | Phosphorylase Kinase; domain 1 | 341 | 436 | - | - | |
Vra8g2539 | 667 | Gene3D | Ribonuclease Inhibitor | 180 | 225 | IPR032675 | - | |
Vra8g2539 | 667 | SUPERFAMILY | L domain-like | 37 | 221 | - | - | |
Vra8g2539 | 667 | Pfam | Leucine rich repeat N-terminal domain | 26 | 63 | IPR013210 | - | |
Vra8g2539 | 667 | MobiDBLite | consensus disorder prediction | 643 | 667 | - | - | |
Vra8g2539 | 667 | MobiDBLite | consensus disorder prediction | 240 | 275 | - | - | |
Vra8g2539 | 667 | Pfam | Protein tyrosine and serine/threonine kinase | 365 | 633 | IPR001245 | GO:0004672|GO:0006468 | |
Vra8g2539 | 667 | CDD | STKc_IRAK | 367 | 637 | - | - | |
Vra8g2539 | 667 | SUPERFAMILY | Protein kinase-like (PK-like) | 365 | 634 | IPR011009 | - | |
Vra8g2539 | 667 | MobiDBLite | consensus disorder prediction | 228 | 275 | - | - | |
Vra8g2539 | 667 | ProSitePatterns | Protein kinases ATP-binding region signature. | 367 | 389 | IPR017441 | GO:0005524 | |
Vra8g2539 | 667 | Gene3D | Transferase(Phosphotransferase) domain 1 | 437 | 654 | - | - | |
Vra8g2539 | 667 | Gene3D | Ribonuclease Inhibitor | 26 | 179 | IPR032675 | - | |
Vra8g2539 | 667 | ProSiteProfiles | Protein kinase domain profile. | 361 | 637 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vra8g2539 | 667 | PANTHER | - | 14 | 653 | - | - | |
Vra8g2539 | 667 | MobiDBLite | consensus disorder prediction | 646 | 667 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vra8g2539 | Vra-Chr8 | 43303061 | 43306369 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vra8g2539 | 28 | 667 | Receptor kinase-like Gene Family | AT1G68400 | 67.173 | 0.0 | 831 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-III | Vra8g2539 | PK_Tyr_Ser-Thr | 9.2e-34 | CL0016 |